Form 8-K - Current report:
SEC Accession No. 0001193125-24-253658
Filing Date
2024-11-08
Accepted
2024-11-08 06:05:03
Documents
14
Period of Report
2024-11-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d882987d8k.htm   iXBRL 8-K 64908
  Complete submission text file 0001193125-24-253658.txt   235037

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acab-20241107.xsd EX-101.SCH 3131
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acab-20241107_def.xml EX-101.DEF 14013
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acab-20241107_lab.xml EX-101.LAB 23272
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acab-20241107_pre.xml EX-101.PRE 14851
17 EXTRACTED XBRL INSTANCE DOCUMENT d882987d8k_htm.xml XML 7215
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Atlantic Coastal Acquisition Corp. II (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41224 | Film No.: 241437829
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)